AU2532299A - Potassium channel polypeptide - Google Patents

Potassium channel polypeptide

Info

Publication number
AU2532299A
AU2532299A AU25322/99A AU2532299A AU2532299A AU 2532299 A AU2532299 A AU 2532299A AU 25322/99 A AU25322/99 A AU 25322/99A AU 2532299 A AU2532299 A AU 2532299A AU 2532299 A AU2532299 A AU 2532299A
Authority
AU
Australia
Prior art keywords
potassium channel
channel polypeptide
polypeptide
potassium
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25322/99A
Inventor
Jayashree Aiyar
Naomi Jean Logsdon
Jianming Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of AU2532299A publication Critical patent/AU2532299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU25322/99A 1998-02-17 1999-02-11 Potassium channel polypeptide Abandoned AU2532299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7499998P 1998-02-17 1998-02-17
US60074999 1998-02-17
PCT/GB1999/000423 WO1999041372A1 (en) 1998-02-17 1999-02-11 Potassium channel polypeptide

Publications (1)

Publication Number Publication Date
AU2532299A true AU2532299A (en) 1999-08-30

Family

ID=22122916

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25322/99A Abandoned AU2532299A (en) 1998-02-17 1999-02-11 Potassium channel polypeptide

Country Status (2)

Country Link
AU (1) AU2532299A (en)
WO (1) WO1999041372A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9907965D0 (en) 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
AUPQ926700A0 (en) * 2000-08-08 2000-08-31 Coroneo, Minas Theodore Methods for preventing pressure induced apoptotic neural cell death
AU2006236018B2 (en) * 2000-08-08 2009-10-01 Minas Theodore Coroneo Methods for preventing pressure induced apoptotic neural cell death
TWI287984B (en) * 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710019A (en) * 1995-06-05 1998-01-20 Human Genome Sciences, Inc. Human potassium channel 1 and 2 proteins
AU7551494A (en) * 1994-07-28 1996-02-22 Human Genome Sciences, Inc. Human potassium channel 1 and 2 proteins

Also Published As

Publication number Publication date
WO1999041372A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
AU1550300A (en) Antigen-binding proteins
AUPP566798A0 (en) Construction technique
AU2434199A (en) Protein
AU2623899A (en) Novel thiobenzamides
AU4411399A (en) Potassium channel inhibitors
AU2350199A (en) Novel aminoorganofunctionalsiloxanes
AU4281999A (en) Peptide
ZA9811591B (en) Potassium channel openers
AU5290999A (en) Simplified window-raiser -
AU3182597A (en) Potassium channel blockers
AU4930399A (en) Novel Polypeptide
AU1077200A (en) Novel chimeric polypeptide
AU4037699A (en) Novel aryl-hydro naphthalenal kanamines
AU3253699A (en) Myxochelines
AU2717399A (en) Two p domains potassium channel
AU2532299A (en) Potassium channel polypeptide
AU2609599A (en) Sensor-coupling
AU5770299A (en) Potassium channel polypeptide and polynucleotide compositions
AU2724799A (en) Novel endo-xylogalacturonase
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU1184800A (en) Novel polypeptide
AU1055399A (en) Rollerboard
AU3835499A (en) Potassium channel subunit
AU3347599A (en) Aeromobile

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase